New Approach for Drug Repurposing Part A by Vijai Singh Hardcover Book

Description: FREE SHIPPING UK WIDE New Approach for Drug Repurposing Part A by Vijai Singh New approach for drug repurposing represents drug discovery and development which is a tedious process that requires 10-15 years of time, investments up to $1-2 billion, and have high risk of failure to enter into market for clinical applications. As the drugs has to pass through number of developmental phase, the likelihood for a drug to be approved from phase I clinical trial to United States of Food and Drug Administration (USFDA) approval is less than 10%. More than 90% of drugs failed in due to toxicity, efficacy and clinical trials. Drug repurposing is one of the roadway to accelerating drug discovery and development for treating disease and thus to providing better quality of life.This volume covers an overview of drug repurposing, novel methods, mechanism of action, lab on chip for drug repurposing, computational biology, system biology, artificial intelligence and machine learning for drug repurposing, target identification, target mining, high throughput drug screening, clinical trial of repurposed drug, repurposed biologics, and regulatory consideration and intellectual property right of repurposed drug. This volume highlights a number of aspects of the drug repurposing that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest. FORMAT Hardcover CONDITION Brand New Author Biography Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University. Table of Contents PrefaceVijai Singh1. An introduction to drug repurposingVijai Singh2. New approaches for drug repurposingGovinda Raj and Deepak Balaji Thimiri Govindaraj3. Reimagining old drugs with new Tricks:Mechanism, strategies and notable success in drug repurposing for neurological disordersPravir Kumar, Samuel Raj, Rashmi K. Ambasta, Neetu Rani, Aastha Kaushik, Shefali Kardam and Sonika Kag4. Lab-on-chip for testing of repurposed drugAlok Pandya5. Computational biology approaches for drug repurposingMustafeez Mujtaba Babar6. Synergizing Drug Repurposing and Target Identification for Neurodegenerative DiseasesPravir Kumar, Mehar Sahu, Shrutikeri Vashishtha, Neha Kukreti, Ashima Gulia, Aashish Russell and Rashmi K. Ambasta7. Artificial Intelligence and ML for drug repurposingAnil G. Jegga and Sudhir Ghandikota8. Genomic approaches for drug repurposingVijai Singh9. Systems biology approaches for drug repurposingAjay Kumar I10. High-throughput screening for drug repurposingSunday N. Okafor, Eze Chinecherem and Ahuchaogu Ikenna11. Approaches of pre-clinical and clinical trials of repurposed drugAjay Kumar I12. Repurposing of biologics and biopharmaceuticalsAjay Kumar I13. Innovative Target Mining Stratagems to Navigate Drug Repurposing EndeavoursSaraswathy Ganesan Rajalekshmi14. Regulatory considerations and intellectual property right of repurposed drugMustafeez Mujtaba Babar Details ISBN0443223386 Publisher Elsevier Science Publishing Co Inc Year 2024 ISBN-13 9780443223389 Format Hardcover Imprint Academic Press Inc Place of Publication San Diego Country of Publication United States Alternative 9780443223396 Audience Professional & Vocational Author Vijai Singh ISBN-10 0443223386 DEWEY 615.19 NZ Release Date 2024-05-31 AU Release Date 2024-05-31 Pages 406 UK Release Date 2024-05-22 Publication Date 2024-05-22 US Release Date 2024-05-22 Series Progress in Molecular Biology and Translational Science We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! 30 DAY RETURN POLICY No questions asked, 30 day returns! FREE DELIVERY No matter where you are in the UK, delivery is free. SECURE PAYMENT Peace of mind by paying through PayPal and eBay Buyer Protection TheNile_Item_ID:160669117;

Price: 187.71 GBP

Location: London

End Time: 2024-12-09T04:46:17.000Z

Shipping Cost: 8.28 GBP